MIDEAST STOCKS-Dubai leads Gulf markets higher; Qatar ends lower

Feb 1 (Reuters) - Dubai stock market closed higher on Wednesday, outperforming the Gulf region, while Qatari stocks retreated amid volatile energy prices. Dubai's benchmark index snapped its losing

New Silkroutes Says Proposed Disposal Of Dental Clinics By Indirect Units

Feb 1 (Reuters) - New Silkroutes: * PROPOSED DISPOSAL OF DENTAL CLINICS BY INDIRECT UNITS OF COMPANY * CO AND SHAREHOLDERS ENTERED INTO BUSINESS TRANSFER AGREEMENT WITH DENTAL HUB IN RELATION TO SALE

Novartis says China still a big growth market as state widens drug availability

BASEL, Feb 1 (Reuters) - Swiss pharmaceutics maker Novartis said on Wednesday China remains a large growth opportunity despite a drop in its population, as the government spurs efforts to make

Virogates Appoints Josephine Baum Jørgensen As New CFO

Feb 1 (Reuters) - ViroGates A/S: * APPOINTS JOSEPHINE BAUM JØRGENSEN AS ITS NEW CFO * JOSEPHINE BAUM JØRGENSEN WILL BE JOINING VIROGATES AS CO'S NEW CFO SUCCEEDING MARK DA SILVA * JOSEPHINE WILL JOIN

Greenlight Biosciences Receives Approval To Initiate Phase I/II Clinical Trial Of Covid-19 mRNA Vaccine Candidate

Feb 1 (Reuters) - Greenlight Biosciences Holdings PBC : * GREENLIGHT BIOSCIENCES RECEIVES APPROVAL TO INITIATE PHASE I/II CLINICAL TRIAL OF COVID-19 MRNA VACCINE CANDIDATE * GREENLIGHT BIOSCIENCES

Hanall Biopharma Says Top-Line Data From Tanfanercept's Phase 3 Expected In H1 2023

Feb 1 (Reuters) - Hanall Biopharma Co Ltd: * HANALL BIOPHARMA REPORTS FULL-YEAR 2022 RESULTS AND PROVIDES BUSINESS UPDATE * HANALL BIOPHARMA CO LTD - TOP-LINE DATA FROM TANFANERCEPT'S PHASE 3 DRY EYE

CytoMed Therapeutics Sees U.S. IPO Of Up To 2.4 Mln Shares - SEC Filing

Feb 1 (Reuters) - Cytomed Therapeutics Pte Ltd: * CYTOMED THERAPEUTICS PTE LTD NOW SEES U.S. IPO OF UP TO 2.4 MILLION ORDINARY SHARES - SEC FILING * CYTOMED THERAPEUTICS PTE LTD SAYS OFFERING PRICE OF

Sherlock Bio to buy UK firm in quest for CRISPR-based handheld diagnostic tests

(Reuters) - Privately-held Sherlock Biosciences said on Wednesday it has acquired UK-based Sense Biodetection to speed up the launch of handheld diagnostic tests that use the breakthrough CRISPR gene

Novartis AG <NVS>: Profits of $1.52 announced for fourth quarter

1 February 2023 11:59 a.m. ​All figures in US dollars. The profits announced by Novartis AG in the fourth quarter were higher than the Refinitiv mean estimate of profits. The company reported profits

Novartis AG <NOVN.S>: Profits of $1.52 announced for fourth quarter

1 February 2023 11:59 a.m. ​All figures in US dollars. The profits announced by Novartis AG in the fourth quarter were higher than the Refinitiv mean estimate of profits. The company reported profits